Short Information | SELLAS Life Sciences Group Inc. (NASDAQ:SLS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,596,625 |
Total Actual Volume | 30,145,817 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 379,831 |
Average Short Percentage | 24.84% |
Is there a SLS Short Squeeze or Breakout about to happen?
See the SLS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-24-2024 | $1.61 | $1.54 | $1.63 | $1.46 | 1,309,912 | 259,367 | 19.8% |
04-23-2024 | $1.54 | $1.63 | $1.72 | $1.46 | 2,015,121 | 404,436 | 20.07% |
04-22-2024 | $1.55 | $1.54 | $1.62 | $1.495 | 1,584,730 | 232,711 | 14.68% |
04-19-2024 | $1.54 | $1.54 | $1.57 | $1.47 | 1,844,272 | 623,410 | 33.8% |
04-18-2024 | $1.46 | $1.52 | $1.53 | $1.4 | 1,598,266 | 407,085 | 25.47% |
04-17-2024 | $1.34 | $1.41 | $1.45 | $1.32 | 563,827 | 138,609 | 24.58% |
04-16-2024 | $1.32 | $1.36 | $1.41 | $1.28 | 1,210,476 | 307,286 | 25.39% |
04-15-2024 | $1.3 | $1.33 | $1.37 | $1.27 | 808,484 | 144,997 | 17.93% |
04-12-2024 | $1.42 | $1.34 | $1.42 | $1.3 | 1,110,235 | 204,321 | 18.4% |
04-11-2024 | $1.39 | $1.4 | $1.41 | $1.31 | 545,748 | 115,755 | 21.21% |
04-10-2024 | $1.38 | $1.39 | $1.48 | $1.33 | 915,486 | 224,820 | 24.56% |
04-09-2024 | $1.47 | $1.4 | $1.4896 | $1.25 | 2,207,857 | 393,669 | 17.83% |
04-08-2024 | $1.38 | $1.445 | $1.49 | $1.36 | 2,297,115 | 661,542 | 28.8% |
04-05-2024 | $1.3 | $1.34 | $1.35 | $1.26 | 955,624 | 368,025 | 38.51% |
04-04-2024 | $1.32 | $1.29 | $1.36 | $1.26 | 2,029,503 | 608,461 | 29.98% |
04-03-2024 | $1.25 | $1.31 | $1.33 | $1.18 | 2,685,087 | 741,210 | 27.6% |
04-02-2024 | $1.1 | $1.18 | $1.24 | $1.07 | 2,411,779 | 652,716 | 27.06% |
04-01-2024 | $1.03 | $1.07 | $1.08 | $0.975 | 1,630,644 | 497,053 | 30.48% |
03-28-2024 | $1.02 | $1.01 | $1.032 | $0.9899 | 1,292,619 | 306,886 | 23.74% |
03-27-2024 | $1.02 | $1.03 | $1.06 | $1 | 1,129,032 | 304,266 | 26.95% |
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
Announced Phase 2a study of SLS009 in r/r AML Showing 50% Response Rate in the Selected Optimal Dose of 30 mg BIW Exceeding the Targeted 20% and 100% Response Rate in Patients with Identified Biomarkers - Completed Enrollment in Phase 3 REGAL Study of Galinpepimut-S in Patients with Acute...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
- Phase 3 REGAL Study of GPS in AML: Enrollment Completed; Steering Committee Guided Interim Analysis Imminent; IDMC Now Scheduled in Late April -...